Clinical Trials in San Francisco

Showing 3481-3500 of 6,211 trials

Brain Health in the Time of COVID-19

NCT04438967

This is a nationwide research program to study the neurological effects of COVID-19. It is open to the public. Healthy individuals and individuals who are or have been infected with COVID-19 are encouraged to join the effort. The study can be done at home with internet access and an iPad or iPhone. Participation takes about one hour. To learn more, go to https://www.mirohealth.com/consent/

Brain Health

Miro Health10,000 participantsStarted Jun 2020

San Francisco, California, United States

COMPLETEDPhase 1< 1 mile

PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma

NCT03139331

This is the first study to evaluate the safety and clinical activity of the combination of oral pazopanib, intravenous or oral irinotecan, and oral temozolomide in pediatric and young adult patients with relapsed or refractory sarcomas. This study will use a 3 + 3 design for dose escalation (Part 1), followed by an expansion cohort (Part 2) at the recommended phase 2 dose level.

SarcomaRefractory Sarcoma

University of California, San Francisco16 participantsStarted Jun 2017

Oakland, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States

COMPLETEDPhase 3< 1 mile

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

NCT01820572

The primary purpose is to assess the benefits and risks of changing from Cyclosporine or Tacrolimus to Belatacept between 6-60 months after kidney transplant.

Kidney Transplantation

Bristol-Myers Squibb446 participantsStarted Mar 2013

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Loma Linda, California, United States +114 more locations

Brain Health in the Time of COVID-19

PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

Find Trials by Condition in San Francisco

Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients

Gliogene: Brain Tumor Linkage Study

A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial Carcinoma

Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)

Study of Efficacy of PEAR-004 in Schizophrenia

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial

Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

Study to Promote Innovation in Rural Integrated Telepsychiatry

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

A Study of CLR325 in Chronic Stable Heart Failure Patients.